Clinical Trial Update: Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A multi-CAR T therapy targeting CD7 is being studied in Phase 1/Phase 2 for CD7-positive malignancies including T-cell acute lymphoblastic leukemia and related …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Natural Killer Cell Lymphoma
• T-cell Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Lymphoma

Drugs mentioned

• Multi-CAR T Cell Therapy targeting CD7

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN